Analysis of Hohn (HC) and porth-a-cath (PAC) central venous catheters (CVC) adverse events (AEs) and related costs in advanced soft tissue sarcomas (STS) treated with trabectedin (TR) 24-hour (24-h) infusion therapy.

Erica Palesandro,Paola Boccone,Lorenzo D'Ambrosio,Danilo Galizia,Sandra Aliberti,Felicino Debernardi,Francesco Bona,Antonio Manca,Giovanni Carlo Anselmetti,Filippo Russo,Delia Campanella,Massimo Aglietta,Giovanni Grignani

Analysis of Hohn (HC) and porth-a-cath (PAC) central venous catheters (CVC) adverse events (AEs) and related costs in advanced soft tissue sarcomas (STS) treated with trabectedin (TR) 24-hour (24-h) infusion therapy.

2017

Erica Palesandro
Paola Boccone
Lorenzo D'Ambrosio
Danilo Galizia
Sandra Aliberti
Felicino Debernardi
Francesco Bona
Antonio Manca
Giovanni Carlo Anselmetti
Filippo Russo
Delia Campanella
Massimo Aglietta
Giovanni Grignani

e20512 Background: TR is registered as second line in STS. The 24-h infusion schedule showed a better activity profile but a CVC is mandatory to administer TR with related costs and possible compli...

Keywords:

Anesthesia
Infusion therapy
Pathology
Trabectedin
Soft tissue
Adverse effect
Medicine
activity profile
second line

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations